Skip to main content
PMC home page
Infection and Immunity logoLink to Infection and Immunity
. 1997 Dec;65(12):4926–4930. doi: 10.1128/iai.65.12.4926-4930.1997

Murine model of recurrent group G streptococcal cellulitis: no evidence of protective immunity.

A L Bisno 1, J M Gaviria 1
PMCID: PMC175710  PMID: 9393777

Abstract

Despite the well-known tendency of cellulitis due to beta-hemolytic streptococci to recur, little is known regarding the mechanisms of human immunity to this infection. We established cellulitis in mice by using a strain of group G streptococcus (1750) originally isolated from the bloodstream of a patient with acute cellulitis. This strain, which has been studied extensively in our laboratory, expresses M protein structurally and functionally analogous to that of group A streptococci, and we have cloned and sequenced the gene encoding this protein (emmMG1). Mice injected with 5 x 10(7) CFU of strain 1750 developed nonlethal necrotic skin and soft tissue infections that healed spontaneously after 14 to 16 days. After healing, the mice were repetitively reinoculated three times with the same challenge dose of 1750. Lesion size did not decrease in severity, size, or time to healing after repetitive challenge. The maximum lesion size and tissue concentration of microorganisms increased between the first and fourth challenges. Pretreatment of 1750 cells with opsonic antisera to MG1 diminished neither the maximum lesion size nor the time course of evolution of the lesions. Thus, in the mouse model used here, there was no evidence of acquired protective immunity to experimentally induced cellulitis.

Full Text

The Full Text of this article is available as a PDF (502.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baddour L. M., Bisno A. L. Non-group A beta-hemolytic streptococcal cellulitis. Association with venous and lymphatic compromise. Am J Med. 1985 Aug;79(2):155–159. doi: 10.1016/0002-9343(85)90003-8. [DOI] [PubMed] [Google Scholar]
  2. Baddour L. M., Bisno A. L. Recurrent cellulitis after coronary bypass surgery. Association with superficial fungal infection in saphenous venectomy limbs. JAMA. 1984 Feb 24;251(8):1049–1052. [PubMed] [Google Scholar]
  3. Baddour L. M., Bisno A. L. Recurrent cellulitis after saphenous venectomy for coronary bypass surgery. Ann Intern Med. 1982 Oct;97(4):493–496. doi: 10.7326/0003-4819-97-4-493. [DOI] [PubMed] [Google Scholar]
  4. Beachey E. H., Stollerman G. H., Johnson R. H., Ofek I., Bisno A. L. Human immune response to immunization with a structurally defined polypeptide fragment of streptococcal M protein. J Exp Med. 1979 Oct 1;150(4):862–877. doi: 10.1084/jem.150.4.862. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Bergner-Rabinowitz S., Ofek I., Davies M. A., Rabinowitz K. Type-specific streptococcal antibodies in pyodermal nephritis. J Infect Dis. 1971 Nov;124(5):488–493. doi: 10.1093/infdis/124.5.488. [DOI] [PubMed] [Google Scholar]
  6. Bessen D., Fischetti V. A. Synthetic peptide vaccine against mucosal colonization by group A streptococci. I. Protection against a heterologous M serotype with shared C repeat region epitopes. J Immunol. 1990 Aug 15;145(4):1251–1256. [PubMed] [Google Scholar]
  7. Binnick A. N., Klein R. B., Baughman R. D. Recurrent erysipelas caused by group B streptococcus organisms. Arch Dermatol. 1980 Jul;116(7):798–799. [PubMed] [Google Scholar]
  8. Bisno A. L., Berrios X., Quesney F., Monroe D. M., Jr, Dale J. B., Beachey E. H. Type-specific antibodies to structurally defined fragments of streptococcal M proteins in patients with acute rheumatic fever. Infect Immun. 1982 Nov;38(2):573–579. doi: 10.1128/iai.38.2.573-579.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Bisno A. L., Craven D. E., McCabe W. R. M proteins of group G streptococci isolated from bacteremic human infections. Infect Immun. 1987 Mar;55(3):753–757. doi: 10.1128/iai.55.3.753-757.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Bisno A. L., Nelson K. E. Type-specific opsonic antibodies in streptococcal pyoderma. Infect Immun. 1974 Dec;10(6):1356–1361. doi: 10.1128/iai.10.6.1356-1361.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Bunce C., Wheeler L., Reed G., Musser J., Barg N. Murine model of cutaneous infection with gram-positive cocci. Infect Immun. 1992 Jul;60(7):2636–2640. doi: 10.1128/iai.60.7.2636-2640.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Campo R. E., Schultz D. R., Bisno A. L. M proteins of group G streptococci: mechanisms of resistance to phagocytosis. J Infect Dis. 1995 Mar;171(3):601–606. doi: 10.1093/infdis/171.3.601. [DOI] [PubMed] [Google Scholar]
  13. Chartier C., Grosshans E. Erysipelas. Int J Dermatol. 1990 Sep;29(7):459–467. doi: 10.1111/j.1365-4362.1990.tb04833.x. [DOI] [PubMed] [Google Scholar]
  14. Chmel H., Hamdy M. Recurrent streptococcal cellulitis complicating radical hysterectomy and radiation therapy. Obstet Gynecol. 1984 Jun;63(6):862–864. [PubMed] [Google Scholar]
  15. Collins C. M., Kimura A., Bisno A. L. Group G streptococcal M protein exhibits structural features analogous to those of class I M protein of group A streptococci. Infect Immun. 1992 Sep;60(9):3689–3696. doi: 10.1128/iai.60.9.3689-3696.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Craven D. E., Rixinger A. I., Bisno A. L., Goularte T. A., McCabe W. R. Bacteremia caused by group G streptococci in parenteral drug abusers: epidemiological and clinical aspects. J Infect Dis. 1986 May;153(5):988–992. doi: 10.1093/infdis/153.5.988. [DOI] [PubMed] [Google Scholar]
  17. DENNY F. W., Jr, PERRY W. D., WANNAMAKER L. W. Type-specific streptococcal antibody. J Clin Invest. 1957 Jul;36(7):1092–1100. doi: 10.1172/JCI103504. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Dale J. B., Baird R. W., Courtney H. S., Hasty D. L., Bronze M. S. Passive protection of mice against group A streptococcal pharyngeal infection by lipoteichoic acid. J Infect Dis. 1994 Feb;169(2):319–323. doi: 10.1093/infdis/169.2.319. [DOI] [PubMed] [Google Scholar]
  19. Fischetti V. A., Bessen D. E., Schneewind O., Hruby D. E. Protection against streptococcal pharyngeal colonization with vaccines composed of M protein conserved regions. Adv Exp Med Biol. 1991;303:159–167. doi: 10.1007/978-1-4684-6000-1_17. [DOI] [PubMed] [Google Scholar]
  20. Flores A. E., Johnson D. R., Kaplan E. L., Wannamaker L. W. Factors influencing antibody responses to streptococcal M proteins in humans. J Infect Dis. 1983 Jan;147(1):1–15. doi: 10.1093/infdis/147.1.1. [DOI] [PubMed] [Google Scholar]
  21. Guirguis N., Fraser D. W., Facklam R. R., El Kholy A., Wannamaker L. W. Type-specific immunity and pharyngeal acquisition of group A Streptococcus. Am J Epidemiol. 1982 Dec;116(6):933–939. doi: 10.1093/oxfordjournals.aje.a113495. [DOI] [PubMed] [Google Scholar]
  22. Jorup-Rönström C. Epidemiological, bacteriological and complicating features of erysipelas. Scand J Infect Dis. 1986;18(6):519–524. doi: 10.3109/00365548609021656. [DOI] [PubMed] [Google Scholar]
  23. Kuttner A. G., Lenert T. F. THE OCCURRENCE OF BACTERIOSTATIC PROPERTIES IN THE BLOOD OF PATIENTS AFTER RECOVERY FROM STREPTOCOCCAL PHARYNGITIS. J Clin Invest. 1944 Mar;23(2):151–161. doi: 10.1172/JCI101478. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. LANCEFIELD R. C. Current knowledge of type-specific M antigens of group A streptococci. J Immunol. 1962 Sep;89:307–313. [PubMed] [Google Scholar]
  25. LANCEFIELD R. C. Persistence of type-specific antibodies in man following infection with group A streptococci. J Exp Med. 1959 Aug 1;110(2):271–292. doi: 10.1084/jem.110.2.271. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Martinez E., Marcos A., Domingo P. Cellulitis after axillary lymph node dissection. Am J Med. 1994 Aug;97(2):201–202. doi: 10.1016/0002-9343(94)90037-x. [DOI] [PubMed] [Google Scholar]
  27. Norrby A., Eriksson B., Norgren M., Rönström C. J., Sjöblom A. C., Karkkonen K., Holm S. E. Virulence properties of erysipelas-associated group A streptococci. Eur J Clin Microbiol Infect Dis. 1992 Dec;11(12):1136–1143. doi: 10.1007/BF01961132. [DOI] [PubMed] [Google Scholar]
  28. Reitmeyer J. C., Macdonald E., Ewert A. Experimental necrotic dermatosis induced by group G streptococci in mice. Arch Dermatol Res. 1982;274(1-2):39–45. doi: 10.1007/BF00510356. [DOI] [PubMed] [Google Scholar]
  29. Reitmeyer J. C., Macdonald E., Tschen E. H., Thomas D., Head C. E. Comparison of skin changes induced on mice by either group A type 12 or group G streptococci. Exp Dermatol. 1992 Dec;1(5):253–258. doi: 10.1111/j.1600-0625.1992.tb00085.x. [DOI] [PubMed] [Google Scholar]
  30. Rothbard S. BACTERIOSTATIC EFFECT OF HUMAN SERA ON GROUP A STREPTOCOCCI : I. TYPE-SPECIFIC ANTIBODIES IN SERA OF PATIENTS CONVALESCING FROM GROUP A STREPTOCOCCAL PHARYNGITIS. J Exp Med. 1945 Aug 1;82(2):93–106. doi: 10.1084/jem.82.2.93. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Schrager H. M., Rheinwald J. G., Wessels M. R. Hyaluronic acid capsule and the role of streptococcal entry into keratinocytes in invasive skin infection. J Clin Invest. 1996 Nov 1;98(9):1954–1958. doi: 10.1172/JCI118998. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Semel J. D., Goldin H. Association of athlete's foot with cellulitis of the lower extremities: diagnostic value of bacterial cultures of ipsilateral interdigital space samples. Clin Infect Dis. 1996 Nov;23(5):1162–1164. doi: 10.1093/clinids/23.5.1162. [DOI] [PubMed] [Google Scholar]
  33. Sjöblom A. C., Eriksson B., Jorup-Rönström C., Karkkonen K., Lindqvist M. Antibiotic prophylaxis in recurrent erysipelas. Infection. 1993 Nov-Dec;21(6):390–393. doi: 10.1007/BF01728920. [DOI] [PubMed] [Google Scholar]
  34. Sriskandan S., Moyes D., Buttery L. K., Krausz T., Evans T. J., Polak J., Cohen J. Streptococcal pyrogenic exotoxin A release, distribution, and role in a murine model of fasciitis and multiorgan failure due to Streptococcus pyogenes. J Infect Dis. 1996 Jun;173(6):1399–1407. doi: 10.1093/infdis/173.6.1399. [DOI] [PubMed] [Google Scholar]
  35. WANNAMAKER L. W., DENNY F. W., PERRY W. D., SIEGEL A. C., RAMMELKAMP C. H., Jr Studies on immunity to streptococcal infections in man. AMA Am J Dis Child. 1953 Sep;86(3):347–348. [PubMed] [Google Scholar]
  36. Watson R. F., Rothbard S., Swift H. F., Technical Assistance of Gilbert de Mello TYPE-SPECIFIC PROTECTION AND IMMUNITY FOLLOWING INTRANASAL INOCULATION OF MONKEYS WITH GROUP A HEMOLYTIC STREPTOCOCCI. J Exp Med. 1946 Jul 31;84(2):127–142. [PMC free article] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES